Category Infection Control & Prevention (IPC)

Sort by:

Direction:

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (181)

View PDF (152)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC

Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP... more

Download (70)

View PDF (1434)

Core components for IPC - Implementation tools and resources

World Health Organization WHO (2020) C_WHO

Based on scientific evidence, expert consensus and country experiences, the WHO core components for infection prevention and control (IPC) are the foundation for establishing or strengthening effective programmes at the national and facility level. These new guidelines on core components of infecti... more

Download (147)

View PDF (689)

ВОДОСНАБЖЕНИЕ, САНИТАРИЯ И ГИГИЕНА В МЕДИЦИНСКИХ УЧРЕЖДЕНИЯХ

World Health Organization WHO; UNICEF (2019) C_WHO

ПРАКТИЧЕСКИЕ ШАГИ ПО ОБЕСПЕЧЕНИЮ ВСЕОБЩЕГО ДОСТУПА К КАЧЕСТВЕННОЙ ПОМОЩИ

Download (1009)

View PDF (2427)

Guidelines on core components of infection prevention and control programmes
recommended

World Health Organization WHO (2016) C_WHO

at the national and acute health care facility level

Download (417)

View PDF (913)

Infection Prevention and Control Assessment Framework at the Facility Level
recommended

World Health Organization WHO (2018) C_WHO

The Infection Prevention and Control (IPC) Assessment Framework (IPCAF) is a tool to support the implementation of the World Health Organization (WHO) Guidelines on core components of IPC programmes at the acute health care facility level. The user should be familiar with the contents of these guide... more

Download (1104)

View PDF (2632)

Guide to Local Production: WHO-recommended Handrub Formulations
recommended

World Health Organization WHO (2010) C_WHO

This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections: Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Users may want to display the material on the wall of ... more

Download (238)

View PDF (258)

Minimum requirements for infection prevention and control programmes

World Health Organization WHO (2020) C_WHO

The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components. The minimum requirements are defined as: I... more

Download (287)

View PDF (242)

Decontamination and reprocessing of medical devices for health care facilities: aide-memoire

World Health Organization WHO (2022) CC

Decontamination of medical devices plays an important role in the prevention of health care-associated infections. It includes cleaning, disinfection and/or sterilization. The processes involved in decontamination are complex, require specific infrastructure and equipment, and involve several sequen... more

Download (65)

View PDF (1175)

Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a pragmatic, cluster-randomised trial in seven low-income and middle-in

NIHR Global Reserach Health Unit on Global Surgery (2022) CC

The Lancet Vol.400 (2022) p.17-67-1776. Published:October 31, 2022DOI:https://doi.org/10.1016/S0140-6736(22)01884-0. Surgical site infection (SSI) is the most common complication of surgery around the world: ChEETAh trial finds routinely changing gloves and instruments for wound closure could preve... more

Download (57)

View PDF (861)

How an ICU works to prevent or treat hospital-acquired infections

Pan American Health Organisation PAHO (2021) C_WHO

Did you know that they are part of Antimicrobial Resistance? Are you clear that we can all do something to avoid them? Marcelo Barbato, intensive care physician and Director of the ICU at Hospital Maciel, the first public hospital in Uruguay with a long history in infection control, tells us.

Download (53)

View PDF (1004)

How to prevent resistant bacteria in hospital facilities. Video

Pan American Health Organisation PAHO (2021) C_WHO

How do they work in an ICC to prevent or mitigate nosocomial infections? Are you clear that we can all do something to avoid them? A simple hand wash can make a difference. Inés Lavega has a degree in nursing and worked for more than 8 years at the CTI of Hospital Maciel, the first public hospit... more

Our Recommendations

New Publications

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

Core components for IPC - Implementation tools and resources

ВОДОСНАБЖЕНИЕ, САНИТАРИЯ И ГИГИЕНА В МЕДИЦИНСКИХ УЧРЕЖДЕНИЯХ

Guidelines on core components of infection prevention and control programmes
recommended

Infection Prevention and Control Assessment Framework at the Facility Level
recommended

Guide to Local Production: WHO-recommended Handrub Formulations
recommended

Minimum requirements for infection prevention and control programmes

Decontamination and reprocessing of medical devices for health care facilities: aide-memoire

Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a pragmatic, cluster-randomised trial in seven low-income and middle-in

How an ICU works to prevent or treat hospital-acquired infections

How to prevent resistant bacteria in hospital facilities. Video

Our Recommendations

New Publications

Infection prevention and control guideline for Ebola and Marburg disease, August 2023 recommended

Guidelines on core components of infection prevention and control programmes recommended

Infection Prevention and Control Assessment Framework at the Facility Level recommended

Guide to Local Production: WHO-recommended Handrub Formulations recommended

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

Guidelines on core components of infection prevention and control programmes
recommended

Infection Prevention and Control Assessment Framework at the Facility Level
recommended

Guide to Local Production: WHO-recommended Handrub Formulations
recommended